Associate Professor Anthony Byrne
PhD MBBS MIPH BAppSc FRACP
Professor Byrne is an internationally respected Respiratory Physician and Global Health researcher based in Sydney, Australia at St Vincent’s hospitals and University of NSW.
He leads the hospital’s Tuberculosis service and is chair of the NSW TB advisory committee and Respiratory Infections Group of the TSANZ. He collaborates across many countries, serves as an expert advisor to the WHO and is secretary and steering committee member for the 4th international Post TB symposia (Korea 2027). Prof Byrne has over 100 peer-reviewed publications that have been cited over 3,000 times, with a H index of 21 and i-10 index of 36.
Current Positions
Senior Staff Specialist in Respiratory Medicine, St Vincent’s Public Hospital, Sydney.
Head of Department Thoracic Medicine St Vincent's private Hospital, Sydney
Conjoint Associate Professor of Medicine: St Vincent’s Clinical School, UNSW.
Chair Respiratory Infections Special Interest Group, Thoracic Society of Australia & New Zealand
Chair New South Wales Tuberculosis Advisory Committee
Co-Chair International Post TB Symposium Steering Committee
Author, Cochrane Clinical Answers, Cochrane Review Group
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
Past 5 Years
1) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. PhD scholarship. (2014-2015).Chronic Respiratory Disease among Successfully Treated Tuberculosis Patients of Lima, Peru. Byrne AL, Marais BJ, Marks GB. $50,000.
2) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2014). Byrne AL, Marais BJ, Mitnick CD, Marks GB. Chronic airflow obstruction after successful treatment of multidrug-resistant tuberculosis. A population-based cohort study in Lima, Peru. $25,000.
3) University of Sydney Postgraduate Research Support Scheme (2014, 2015). Byrne AL. Pulmones Post TB (Lungs after tuberculosis). Project support $12,000.
4) Woolcock Institute of Medical Research Fund (2015, 2016). Byrne AL. Marais BJ, Marks GB “Pulmones Post TB” (Lungs after tuberculosis). Project support $15,000.
5) National Health & Medical Research Council Tuberculosis Centre of Research Excellence. Seed Funding. (2017). Byrne AL, Marais BJ, Marriott D. The use of therapeutic drug monitoring to improve clinical outcomes for patients with pulmonary tuberculosis; a pilot study. $25,000
Committees
1) Thoracic Society of Australia and New Zealand, New South Wales Branch. (TSANZ). Elected executive committee member. (2017-ongoing).
2) New South Wales Tuberculosis Program. Expert panel member (2017- ongoing).
3) St Vincent’s Hospital Drug Committee member (2018- ongoing).
4) The V-QUIN MDR TRIAL: Expert Panel Member to review adverse events. The V-QUIN trial is a multicentre, randomised controlled trial to assess the efficacy of 6 months of levofloxacin preventative therapy for household contacts of multidrug resistant tuberculosis patients in Vietnam.
5) St Vincent’s hospital tuberculosis working group. Founding member (2015-ongoing).
Collaborative research
Current member;
• NHMRC Tuberculosis Centre of Research Excellence • International Union Against Tuberculosis and Lung Disease
• Harvard Medical School Global Health and Social Medicine Tuberculosis Research Group
• Partners In Health (Socios En Salud Sucursal, Peru) Principal Investigator
• Associate Investigator International Research and Development (IRD; a global health delivery and research organization based in Pakistan).
Reviewer
Journals: Respirology, BMC Respiratory, International Journal of chronic obstructive pulmonary disease, Journal of Thoracic Disease & others.
My Teaching
Undergraduate, postgraduate, junior medical officer (JMO) and basic & advanced trainee teaching and supervision.
Examiner: undergraduate exams (FRACP clinical exam), ATs.
Research supervision including AT projects.